We need everybody help to stress the importance of in silico medicine in the work programme for Health: support our policy activities!
In the draft of the work programme for Health, demographic change and wellbeing (that eHealth belongs too now), eHealth is unfortunately all too frequently interpreted as mHealth (mobile health) or tele-Health, leaving very little room for in silico medicine and VPH-like research. At this moment, the member states are being consulted for feedback which they will have to deliver shortly. We call on every one of you to get in touch with your national contact point as soon as possible and ask them to stress the importance of in silico medicine in the work programme for Health.
A request of collaboration has already been sent to all VPHI members, but if everybody can get engaged. Contact the Policy Affairs Work Group (PAWG) if you wish to get involved (email to: email@example.com)
In the meanwhile, the PAWG is in close contact with a number of MEPs that are supportive of VPH and who have expressed an interest in tabling a Question for Written Answer to the European Commission, expressing concern that support for in silico medicine is not specifically mentioned in the current draft of the Horizon 2020 2014 work programme.